Literature DB >> 31690937

Performance of Five Ultrasound Risk Stratification Systems in Selecting Thyroid Nodules for FNA.

Marco Castellana1, Carlo Castellana2, Giorgio Treglia3,4, Francesco Giorgino1, Luca Giovanella3,5, Gilles Russ6,7, Pierpaolo Trimboli3,8.   

Abstract

CONTEXT: Ultrasound (US) risk stratification systems (RSSs) have been developed to reduce the number of unnecessary fine-needle aspiration procedures (FNA) in patients with thyroid nodules.
OBJECTIVE: We conducted a systematic review and meta-analysis evaluating the ability of the 5 most common US RSSs for the appropriate selection of thyroid nodules for FNA. DATA SOURCES: This systematic review and meta-analysis was registered on PROSPERO (CRD42019131771). PubMed, CENTRAL, Scopus, and Web of Science were searched until March 2019. STUDY SELECTION: Original articles reporting data on the performance of AACE/ACE/AME, ACR TI-RADS, ATA, EU-TIRADS, and K-TIRADS were included. DATA EXTRACTION: The number of nodules classified as true negative, true positive, false negative, and false positive was extracted. Summary operating points were estimated using a random-effects model. Interobserver agreement was also assessed. DATA SYNTHESIS: Twelve studies evaluating 18 750 thyroid nodules were included. Participants were adult outpatients with thyroid nodules submitted to either FNA or core-needle biopsy or surgery and with available US images. The final diagnosis for malignant nodules was generally based on histology, while cytology was used for benign nodules. Diagnostic odds ratio (DOR) ranged from 2.2 to 4.9. A head-to-head comparison showed a higher relative DOR for ACR-TIRADS versus ATA (P = .002) or K-TIRADS (P = .002), due to a higher relative likelihood ratio for positive results.
CONCLUSIONS: The present meta-analysis found a higher performance of ACR TI-RADS in selecting thyroid nodules for FNA. However, the comparison across the most common US RSSs was limited by the data available. Further studies are needed to confirm this finding. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  diagnostic performance; meta-analysis; systematic review; thyroid nodule; ultrasound

Year:  2020        PMID: 31690937     DOI: 10.1210/clinem/dgz170

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference.

Authors:  Pierpaolo Trimboli; Marco Castellana; Camilla Virili; Roald Flesland Havre; Fabiano Bini; Franco Marinozzi; Ferdinando D'Ambrosio; Francesco Giorgino; Luca Giovanella; Helmut Prosch; Giorgio Grani; Maija Radzina; Vito Cantisani
Journal:  Radiol Med       Date:  2020-01-22       Impact factor: 3.469

Review 2.  Thyroid Nodule Evaluation and Management in Older Adults: A Review of Practical Considerations for Clinical Endocrinologists.

Authors:  Naykky Singh Ospina; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2021-02-12       Impact factor: 3.443

3.  Ultrasound-Based Indications for Thyroid Fine-Needle Aspiration: Outcome of a TIRADS-Based Approach versus Operators' Expertise.

Authors:  Tamas Solymosi; Laszlo Hegedüs; Steen Joop Bonnema; Andrea Frasoldati; Laszlo Jambor; Gabor Laszlo Kovacs; Enrico Papini; Karoly Rucz; Gilles Russ; Zsolt Karanyi; Endre V Nagy
Journal:  Eur Thyroid J       Date:  2020-11-25

4.  Development and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules.

Authors:  Naykky M Singh Ospina; Diliara Bagautdinova; Ian Hargraves; Diana Barb; Sreevidya Subbarayan; Ashok Srihari; Shu Wang; Spyridoula Maraka; Carma L Bylund; Debbie Treise; Victor Montori; Juan P Brito
Journal:  Clin Endocrinol (Oxf)       Date:  2021-09-29       Impact factor: 3.478

5.  Summary of Meta-analyses of Studies Involving TIRADS Classifications (EU-TIRADS, ACR-TIRADS, and K-TIRADS) in Evaluating the Malignant Potential of Focal Lesions of The Thyroid Gland.

Authors:  Katarzyna Dobruch-Sobczak; Zbigniew Adamczewski; Marek Dedecjus; Andrzej Lewiński; Bartosz Migda; Marek Ruchała; Anna Skowrońska-Szcześniak; Ewelina Szczepanek-Parulska; Klaudia Zajkowska; Agnieszka Żyłka
Journal:  J Ultrason       Date:  2022-04-27

6.  Approaching Indeterminate Thyroid Nodules in the Absence of Molecular Markers: "The BETH-TR Score".

Authors:  Sushma Mehta; Subramanian Kannan
Journal:  Indian J Endocrinol Metab       Date:  2020-04-30

7.  Evaluation of the Diagnostic Performance of EU-TIRADS in Discriminating Benign from Malignant Thyroid Nodules: A Prospective Study in One Referral Center.

Authors:  Roussanka D Kovatcheva; Alexander D Shinkov; Inna D Dimitrova; Ralitsa B Ivanova; Kalin N Vidinov; Radina S Ivanova
Journal:  Eur Thyroid J       Date:  2020-05-18

8.  Performance of current ultrasound-based malignancy risk stratification systems for thyroid nodules in patients with follicular neoplasms.

Authors:  Haixia Guan; Jian Kuang; Yinghe Lin; Shuiqing Lai; Peiqing Wang; Jinlian Li; Zhijiang Chen; Long Wang
Journal:  Eur Radiol       Date:  2022-01-01       Impact factor: 7.034

Review 9.  Contemporary Thyroid Nodule Evaluation and Management.

Authors:  Giorgio Grani; Marialuisa Sponziello; Valeria Pecce; Valeria Ramundo; Cosimo Durante
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

10.  Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?

Authors:  James J Figge; William E Gooding; David L Steward; Linwah Yip; Rebecca S Sippel; Samantha Peiling Yang; Randall P Scheri; Jennifer A Sipos; Susan J Mandel; Sarah E Mayson; Kenneth D Burman; Jessica M Folek; Bryan R Haugen; Julie A Sosa; Rajeev Parameswaran; Wee Boon Tan; Yuri E Nikiforov; Sally E Carty
Journal:  Thyroid       Date:  2021-09-01       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.